SynthesisInternational urology and nephrology2026

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for ARPI-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer: a pooled analysis of KEYNOTE-921 and CheckMate 7DX trials.

Qi Zou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.